Global Ocular Drug Delivery Technology Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Ocular Drug Delivery Technology Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Ocular administration of drug isprimarily associated with the need totreat ophthalmic diseases.
Ocular Drug Delivery Technology report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Ocular Drug Delivery Technology market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospitals and Ambulatory Surgical Centers are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Ocular Drug Delivery Technology industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Ocular Drug Delivery Technology key companies include OCULAR THERAPEUTIX, Alimera Sciences, EyeGate Pharma, Bausch Health, Envisia Therapeutics, Clearside Biomedical, Graybug Vision and Taiwan Liposome Company, etc. OCULAR THERAPEUTIX, Alimera Sciences, EyeGate Pharma are top 3 players and held % share in total in 2022.
Ocular Drug Delivery Technology can be divided into Topical, Ocular Inserts, Iontophoresis and Intraocular Implants, etc. Topical is the mainstream product in the market, accounting for % share globally in 2022.
Ocular Drug Delivery Technology is widely used in various fields, such as Hospitals, Ambulatory Surgical Centers and Clinics,, etc. Hospitals provides greatest supports to the Ocular Drug Delivery Technology industry development. In 2022, global % share of Ocular Drug Delivery Technology went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ocular Drug Delivery Technology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
OCULAR THERAPEUTIX
Alimera Sciences
EyeGate Pharma
Bausch Health
Envisia Therapeutics
Clearside Biomedical
Graybug Vision
Taiwan Liposome Company
Segment by Type
Topical
Ocular Inserts
Iontophoresis
Intraocular Implants
Hospitals
Ambulatory Surgical Centers
Clinics
By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Ocular Drug Delivery Technology market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Ocular Drug Delivery Technology introduction, etc. Ocular Drug Delivery Technology Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Ocular Drug Delivery Technology market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Ocular Drug Delivery Technology report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Ocular Drug Delivery Technology market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospitals and Ambulatory Surgical Centers are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Ocular Drug Delivery Technology industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Ocular Drug Delivery Technology key companies include OCULAR THERAPEUTIX, Alimera Sciences, EyeGate Pharma, Bausch Health, Envisia Therapeutics, Clearside Biomedical, Graybug Vision and Taiwan Liposome Company, etc. OCULAR THERAPEUTIX, Alimera Sciences, EyeGate Pharma are top 3 players and held % share in total in 2022.
Ocular Drug Delivery Technology can be divided into Topical, Ocular Inserts, Iontophoresis and Intraocular Implants, etc. Topical is the mainstream product in the market, accounting for % share globally in 2022.
Ocular Drug Delivery Technology is widely used in various fields, such as Hospitals, Ambulatory Surgical Centers and Clinics,, etc. Hospitals provides greatest supports to the Ocular Drug Delivery Technology industry development. In 2022, global % share of Ocular Drug Delivery Technology went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ocular Drug Delivery Technology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
OCULAR THERAPEUTIX
Alimera Sciences
EyeGate Pharma
Bausch Health
Envisia Therapeutics
Clearside Biomedical
Graybug Vision
Taiwan Liposome Company
Segment by Type
Topical
Ocular Inserts
Iontophoresis
Intraocular Implants
Segment by Application
Hospitals
Ambulatory Surgical Centers
Clinics
By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Ocular Drug Delivery Technology market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Ocular Drug Delivery Technology introduction, etc. Ocular Drug Delivery Technology Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Ocular Drug Delivery Technology market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.